TITLE

Is bigger better? An argument for very low starting doses

AUTHOR(S)
McCormack, James P.; Allan, G. Michael; Virani, Adil S.
PUB. DATE
January 2011
SOURCE
CMAJ: Canadian Medical Association Journal;1/11/2011, Vol. 183 Issue 1, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on having a low dose approach when taking new medications. According to the authors, having a low dose approach can decrease the risk of unwanted effects, engage patients in identifying the best dosage for them and provide a placebo effect. They added that starting with a higher dose may cause dose-related side-effects to the patients.
ACCESSION #
58607178

 

Related Articles

  • Time to rethink dose-finding study design.  // Nature Reviews Drug Discovery;Dec2013, Vol. 12 Issue 12, p895 

    The article offers information on the benefits of Multiple Comparison Procedure-Modelling (MCP-MOD) approach over traditional approaches for testing the doses of drugs against placebo, an ineffectual treatment for diseases.

  • Open-Label Dose Optimization of Methylphenidate Modified Release Long Acting (MPH-LA): A Post Hoc Analysis of Real-Life Titration from a 40-Week Randomized Trial. Huss, Michael; Ginsberg, Ylva; Arngrim, Torben; Philipsen, Alexandra; Carter, Katherine; Chen, Chien-Wei; Gandhi, Preetam; Kumar, Vinod // Clinical Drug Investigation;Sep2014, Vol. 34 Issue 9, p639 

    Background and Objectives: In the management of attention-deficit hyperactivity disorder (ADHD) in adults it is important to recognize that individual patients respond to a wide range of methylphenidate doses. Studies with methylphenidate modified release long acting (MPH-LA) in children have...

  • High-dose simvastatin fails to achieve primary end point in trial of ACS.  // Formulary;Oct2004, Vol. 39 Issue 10, p480 

    This article focuses on how initiating high-dose simvastatin early after an acute coronary syndrome (ACS) event does not result in significantly superior clinical outcomes compared to delayed initiation of low-dose simvastatin. Among patients randomized to placebo followed by simvastatin, the...

  • Glucosamine improves symptoms of osteoarthritis, but further studies on its disease-modifying effects are needed. Adis International Limited // Drugs & Therapy Perspectives;Oct2004, Vol. 20 Issue 10, p1 

    Presents information on glucosamine. Discussion on its mechanism of action; Results of a 3-year placebo-controlled trials conducted on glucosamine; Dosage and administration.

  • Effects of Allium sativum (Garlic) on systolic and diastolic blood pressure in patients with essential hypertension. Ashraf, Rizwan; Khan, Rafeeq Alam; Ashraf, Imran; Qureshi, Absar A. // Pakistan Journal of Pharmaceutical Sciences;Sep2013, Vol. 26 Issue 5, p859 

    The present study evaluated the effects of garlic on blood pressure in patients with essential hypertension. Patients (n=210) with stage 1 essential hypertension were divided into 7 groups named as A, B, C, D, E, F and G. Each group comprised of 30 patients. Each patient in group A, B, C, D and...

  • Elderly Patients May Benefit From Flu Vaccine Dosage Change.  // RN;Jul2006, Vol. 69 Issue 7, p17 

    The article focuses on a study that discovered the advantage of giving higher-than-normal doses of the influenza vaccine to elderly patients. Different doses of the vaccine and placebo were randomly assigned to approximately 200 adults. Side effects were determined and blood tests were performed...

  • Personalized dosing tailors the medication to the patient. Claycomb, Joel // Drug Topics;Dec2015, Vol. 159 Issue 12, p48 

    The article discusses the emergence of personalized dosing of medications that increased patient responses to therapy and the potential for reduction of harm. Medication can be made unique through development of novel dosage forms and expanded use of 3-D printing. Topics discussed includes role...

  • Delayed-release caps for pancreatic disorder.  // Clinical Advisor;Mar2010, Vol. 13 Issue 3, p15 

    The article offers information on Zenpep from Eurand NV, a drug intended for treating patients with pancreatic disorders in the U.S. It notes that Zenpep is composed of lipase of 10,000 units, protease of 17,000 units, and amylase with 27,000 units. According to a double-blind crossover study,...

  • The Effect of Chlorpromazine and Chlordiazepoxide on Cognitive Functioning. Brimer, A.; Schnieden, H.; Simon, A. // British Journal of Psychiatry;Sep64, Vol. 110 Issue 468, p723 

    The article examines the effect of chlorpromazine and chlordiazepoxide on cognitive functioning, the performance in problem solving situations as well as in tests involving speed and accuracy. Using a cross-over technique, results showed both drugs depressed the response to certain psychological...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics